Ullet index:DAIICHI SANKYO COMPANY, LIMITED:4568

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index DAIICHI SANKYO COMPANY, LIMITED Go to web site 4568 Medicals 東証プライム March 1, 2000 2005.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp

DAIICHI SANKYO COMPANY, LIMITED mark.gifUllet indexHelp  (Unit:Millions of Yen)

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Shareholder's EquityHelp - - - - -
Shareholder's EquityHelp (*include Wire-Down) 1,688,174
plusup
1,445,854
plusup
1,350,872
plusup
1,272,053
plusdown
1,305,810
plus
Increase and decrease in current net earnings(*include Wire-Down) - - - - -
Net IncomeHelp 200,732
plusup
109,188
plusup
66,973
plusdown
75,956
plusdown
129,075
plus
Operating Cash Flow(OFC)Help 590,036
plusup
114,514
plusdown
139,226
plusdown
192,207
plusdown
196,601
plus
Free Cash Flow(FCF)Help 307,400
plusup
-143,268
plusdown
351,565
plusup
152,961
plusdown
278,274
plus
OFC - Net IncomeHelp 74
plusup
72
plusup
66
plusup
65
plusdown
65
plus
Current AssetsHelp - - - - -
FCF / Current AssetsHelp 117.45%
plusup
21.46%
plusdown
22.54%
plusdown
31.06%
plusup
25.60%
plus
Current Assets / Amount of SalesHelp 31.37%
plusdown
41.75%
plusdown
59.13%
plusdown
64.28%
plusdown
78.24%
plus
Free Cash Revenue RatioHelp 19.19%
plusup
-11.21%
plusdown
33.65%
plusup
15.89%
plusdown
28.34%
plus

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

DAIICHI SANKYO COMPANY, LIMITED
MAMIYA-OP CO.,LTD.
Ube Material Industries,Ltd.
BancTec Japan, Inc.
TAIYO KAGAKU CO.,LTD.

Company where related level is highHelp

Cyfuse Biomedical K.K.
TAISHO PHARMACEUTICAL CO.,LTD.
Medrx Co.,Ltd.
RaQualia Pharma Inc.
HEALIOS K.K.
TSUMURA & CO.
PeptiDream Inc.
SymBio Pharmaceuticals Limited
UMN Pharma Inc.
ASKA Pharmaceutical Co.,Ltd.